Pirfenidone Capsule 267 Mg + Fluvoxamine Interaction
Majorinteraction on record
Description
Strong CYP1A2 inhibitor significantly increases pirfenidone exposure. Concomitant use is not recommended; discontinue fluvoxamine prior to pirfenidone administration or reduce pirfenidone to 267 mg three times daily.
Mechanism
CYP1A2 inhibition
Source: NLP:pirfenidone capsule, 267 mg